Loomis, Sayles & Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.7M | Sell |
1,425,779
-23,063
| -2% | -$1.17M | 0.1% | 70 |
|
|
2025
Q4 | $72M | Buy |
1,448,842
+162,905
| +13% | +$7.92M | 0.09% | 72 |
|
|
2025
Q3 | $61.5M | Sell |
1,285,937
-11,921
| -0.9% | -$480K | 0.07% | 92 |
|
|
2025
Q2 | $40.9M | Sell |
1,297,858
-142,786
| -10% | -$4.58M | 0.05% | 133 |
|
|
2025
Q1 | $47.2M | Sell |
1,440,644
-26,383
| -2% | -$935K | 0.07% | 109 |
|
|
2024
Q4 | $53M | Sell |
1,467,027
-49,096
| -3% | -$1.73M | 0.07% | 119 |
|
|
2024
Q3 | $47.3M | Sell |
1,516,123
-40,038
| -3% | -$1.25M | 0.06% | 137 |
|
|
2024
Q2 | $41.6M | Sell |
1,556,161
-41,256
| -3% | -$1.2M | 0.06% | 144 |
|
|
2024
Q1 | $54.5M | Sell |
1,597,417
-39,073
| -2% | -$1.16M | 0.08% | 110 |
|
|
2023
Q4 | $47.4M | Sell |
1,636,490
-93,779
| -5% | -$2.49M | 0.07% | 130 |
|
|
2023
Q3 | $47.7M | Buy |
1,730,269
+136,964
| +9% | +$4.17M | 0.08% | 115 |
|
|
2023
Q2 | $47.9M | Buy |
1,593,305
+33,243
| +2% | +$1.16M | 0.08% | 117 |
|
|
2023
Q1 | $56.5M | Buy |
1,560,062
+527
| +0% | +$20.3K | 0.1% | 105 |
|
|
2022
Q4 | $55.6M | Sell |
1,559,535
-41,768
| -3% | -$1.45M | 0.11% | 101 |
|
|
2022
Q3 | $54.2M | Sell |
1,601,303
-9,659
| -0.6% | -$314K | 0.11% | 93 |
|
|
2022
Q2 | $46.6M | Sell |
1,610,962
-18,698
| -1% | -$536K | 0.09% | 106 |
|
|
2022
Q1 | $52.7M | Sell |
1,629,660
-41,554
| -2% | -$1.27M | 0.07% | 119 |
|
|
2021
Q4 | $48.7M | Buy |
1,671,214
+20,647
| +1% | +$626K | 0.06% | 153 |
|
|
2021
Q3 | $44M | Buy |
1,650,567
+31,502
| +2% | +$846K | 0.05% | 180 |
|
|
2021
Q2 | $49.9M | Buy |
1,619,065
+1,186,742
| +275% | +$36.4M | 0.06% | 150 |
|
|
2021
Q1 | $11.3M | Buy |
432,323
+82,195
| +23% | +$2.3M | 0.01% | 376 |
|
|
2020
Q4 | $8.81M | Sell |
350,128
-11,874
| -3% | -$256K | 0.01% | 391 |
|
|
2020
Q3 | $7.54M | Sell |
362,002
-1,500
| -0.4% | -$34K | 0.01% | 363 |
|
|
2020
Q2 | $8.63M | Sell |
363,502
-12,269
| -3% | -$271K | 0.01% | 340 |
|
|
2020
Q1 | $6.76M | Sell |
375,771
-258,530
| -41% | -$5.43M | 0.01% | 346 |
|
|
2019
Q4 | $15M | Sell |
634,301
-482,266
| -43% | -$11.7M | 0.03% | 274 |
|
|
2019
Q3 | $30.7M | Buy |
1,116,567
+113,138
| +11% | +$3.35M | 0.06% | 143 |
|
|
2019
Q2 | $33.2M | Buy |
1,003,429
+578,301
| +136% | +$19.8M | 0.06% | 133 |
|
|
2019
Q1 | $14.9M | Sell |
425,128
-18,856
| -4% | -$702K | 0.03% | 259 |
|
|
2018
Q4 | $14.7M | Sell |
443,984
-129,228
| -23% | -$5.56M | 0.03% | 226 |
|
|
2018
Q3 | $28.9M | Sell |
573,212
-6,460
| -1% | -$319K | 0.06% | 164 |
|
|
2018
Q2 | $34.7M | Buy |
579,672
+5,619
| +1% | +$291K | 0.07% | 135 |
|
|
2018
Q1 | $26.3M | Sell |
574,053
-20,341
| -3% | -$849K | 0.06% | 175 |
|
|
2017
Q4 | $23.7M | Sell |
594,394
-54,012
| -8% | -$2.13M | 0.05% | 228 |
|
|
2017
Q3 | $25.9M | Sell |
648,406
-19,583
| -3% | -$847K | 0.06% | 213 |
|
|
2017
Q2 | $28.8M | Sell |
667,989
-22,635
| -3% | -$806K | 0.07% | 178 |
|
|
2017
Q1 | $21.6M | Sell |
690,624
-15,537
| -2% | -$416K | 0.05% | 233 |
|
|
2016
Q4 | $17.8M | Sell |
706,161
-36,543
| -5% | -$817K | 0.04% | 295 |
|
|
2016
Q3 | $18.4M | Sell |
742,704
-20,424
| -3% | -$462K | 0.05% | 287 |
|
|
2016
Q2 | $15.5M | Buy |
763,128
+762,342
| +96,990% | +$13.5M | 0.04% | 336 |
|
|
2016
Q1 | $12K | Buy |
786
+542
| +222% | +$7.07K | ﹤0.01% | 795 |
|
|
2015
Q4 | $3K | Buy |
+244
| New | +$3.77K | ﹤0.01% | 971 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
